Effects of Chk1 inhibitor or paclitaxel on cisplatin-induced cell-cycle kinetics and survival in parental and cisplatin-resistant HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci)
Integrative Cancer Science and Therapeutics · 2015
DOI: 10.15761/icst.1000120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Cancer Science and Therapeutics, 2015.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2015). Effects of Chk1 inhibitor or paclitaxel on cisplatin-induced cell-cycle kinetics and survival in parental and cisplatin-resistant HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci). Integrative Cancer Science and Therapeutics. https://doi.org/10.15761/icst.1000120
Vancouver
Effects of Chk1 inhibitor or paclitaxel on cisplatin-induced cell-cycle kinetics and survival in parental and cisplatin-resistant HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci). Integrative Cancer Science and Therapeutics. 2015. doi:10.15761/icst.1000120
BibTeX
@article{euvimed2015,
title = {Effects of Chk1 inhibitor or paclitaxel on cisplatin-induced cell-cycle kinetics and survival in parental and cisplatin-resistant HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci)},
journal = {Integrative Cancer Science and Therapeutics},
year = {2015},
doi = {10.15761/icst.1000120}
}
EUVIMED